Zainal, Nurhafiza <br/><br/>
Resveratrol treatment reveals a novel role for HMGB1 in regulation of the type 1 interferon response in dengue virus infection.  [electronic resource] 

 -  Scientific reports  02 2017 
 - 42998 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2045-2322 
<br/><br/><label>Standard No.: </label>10.1038/srep42998  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antiviral Agents--pharmacology<br/>Cell Line, Tumor<br/>Cell Nucleus--metabolism<br/>Dengue--drug therapy<br/>Dengue Virus--isolation & purification<br/>HMGB1 Protein--antagonists & inhibitors<br/>Humans<br/>Interferon Type I--genetics<br/>Interferon-beta--genetics<br/>Myxovirus Resistance Proteins--genetics<br/>Promoter Regions, Genetic<br/>Protein Binding<br/>RNA Interference<br/>RNA, Small Interfering--metabolism<br/>Resveratrol<br/>Sirtuin 1--antagonists & inhibitors<br/>Stilbenes--pharmacology<br/>Virus Replication--drug effects